Status: Not yet recruiting
Postprandial Regulation of Bone Perfusion in Healthy Individuals
The goal of this clinical trial is to learn whether certain natural hormones - Glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide-2, (GLP-2), and amylin - affect blood flow to the bones.
Participants needed: 15
Trial details
Age: 25-50Biological sex: AllType: InterventionalSponsor: University of CopenhagenUpdated: Jul 1, 2026Locations: 1
Eligibility criteria
Age 25-50 years. [+4]
Bone disease incl. confirmed osteopenia. [+10]